Systematic Evaluation of Light-Activatable Biohybrids for Anti-Glioma Photodynamic Therapy

Photosensitizing biomolecules (PSBM) represent a new generation of light-absorbing compounds with improved optical and physicochemical properties for biomedical applications. Despite numerous advances in lipid-, polymer-, and protein-based PSBMs, their effective use requires a fundamental understanding of how macromolecular structure influences the physicochemical and biological properties of the photosensitizer. Here, we prepared and characterized three well-defined PSBMs based on a clinically used photosensitizer, benzoporphyrin derivative (BPD). The PSBMs include 16:0 lysophosphocholine-BPD (16:0 Lyso PC-BPD), distearoyl-phosphoethanolamine-polyethylene-glycol-BPD (DSPE-PEG-BPD), and anti-EGFR cetuximab-BPD (Cet-BPD). In two glioma cell lines, DSPE-PEG-BPD exhibited the highest singlet oxygen yield but was the least phototoxic due to low cellular uptake. The 16:0 Lyso PC-BPD was most efficient in promoting cellular uptake but redirected BPD’s subcellular localization from mitochondria to lysosomes. At 24 h after incubation, proteolyzed Cet-BPD was localized to mitochondria and effectively disrupted the mitochondrial membrane potential upon light activation. Our results revealed the variable trafficking and end effects of PSBMs, providing valuable insights into methods of PSBM evaluation, as well as strategies to select PSBMs based on subcellular targets and cytotoxic mechanisms. We demonstrated that biologically informed combinations of PSBMs to target lysosomes and mitochondria, concurrently, may lead to enhanced therapeutic effects against gliomas.

[1]  Heidi Abrahamse,et al.  New Photosensitizers For Photodynamic Therapy , 1990, [1990] Proceedings of the Twelfth Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[2]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[3]  Hisataka Kobayashi,et al.  Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.

[4]  P. Oehr,et al.  [Clinical use of photodynamic therapy in gynecologic tumor patients--antibody-targeted photodynamic laser therapy as a new oncologic treatment procedure]. , 1992, Zentralblatt fur Gynakologie.

[5]  T. Hasan,et al.  Benzophenothiazine and Benzoporphyrin Derivative Combination Phototherapy Effectively Eradicates Large Murine Sarcomas , 1996, Photochemistry and photobiology.

[6]  T. Hasan,et al.  Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent , 2018, Lasers in surgery and medicine.

[7]  E. Tsuchida,et al.  Self-organized lipid-porphyrin bilayer membranes in vesicular form: nanostructure, photophysical properties, and dioxygen coordination. , 2002, Chemistry.

[8]  Michael R Hamblin,et al.  Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.

[9]  Tayyaba Hasan,et al.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.

[10]  Mark D. Savellano,et al.  Photochemical Targeting of Epidermal Growth Factor Receptor: A Mechanistic Study , 2005, Clinical Cancer Research.

[11]  M. Gottesman,et al.  Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells. , 2019, Cancer letters.

[12]  M. Baptista,et al.  Parallel damage in mitochondria and lysosomes is an efficient way to photoinduce cell death , 2018, Autophagy.

[13]  A. Moor,et al.  Signaling pathways in cell death and survival after photodynamic therapy. , 2000, Journal of photochemistry and photobiology. B, Biology.

[14]  D. Kessel,et al.  Mitochondrial photodamage and PDT-induced apoptosis. , 1998, Journal of photochemistry and photobiology. B, Biology.

[15]  Michael R Hamblin,et al.  Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy , 2003, British Journal of Cancer.

[16]  M. Goldenberg,et al.  Pharmaceutical approval update. , 2013, P & T : a peer-reviewed journal for formulary management.

[17]  T. Hasan,et al.  Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects. , 2018, Small.

[18]  R Birngruber,et al.  Vascular targeting in photodynamic occlusion of subretinal vessels. , 1994, Ophthalmology.

[19]  T. Hasan,et al.  The "Nano" World in Photodynamic Therapy. , 2014, Austin journal of nanomedicine & nanotechnology.

[20]  T. Hasan,et al.  Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer , 2014, British Journal of Cancer.

[21]  T. Hasan,et al.  A Combination of Visudyne and a Lipid‐anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer , 2019, Photochemistry and photobiology.

[22]  T. Hasan,et al.  Photonanomedicine: a convergence of photodynamic therapy and nanotechnology. , 2016, Nanoscale.

[23]  Thomas Pongratz,et al.  ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[24]  C. James,et al.  Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response , 2006, Clinical Cancer Research.

[25]  Tayyaba Hasan,et al.  The role of photodynamic therapy in overcoming cancer drug resistance , 2015, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[26]  D. Kessel,et al.  Evidence that bcl-2 is the Target of Three Photosensitizers that Induce a Rapid Apoptotic Response¶ , 2001, Photochemistry and photobiology.

[27]  N. Bressler.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. , 2001 .

[28]  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. , 2001 .

[29]  S. Neelamegham,et al.  Functionalization of Cobalt Porphyrin-Phospholipid Bilayers with His-tagged Ligands and Antigens , 2015, Nature chemistry.

[30]  Brian W. Pogue,et al.  Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery. , 2018, Cancer research.

[31]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[32]  M. S. Baptista,et al.  Methylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells , 2017, BMC Cancer.

[33]  D. Kessel,et al.  Promotion of Proapoptotic Signals by Lysosomal Photodamage , 2015, Photochemistry and photobiology.

[34]  D. Kessel.  Photodynamic therapy: Promotion of efficacy by a sequential protocol. , 2016, Journal of porphyrins and phthalocyanines.

[35]  Bryan Q. Spring,et al.  A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways , 2015, Nature nanotechnology.

[36]  Tayyaba Hasan,et al.  Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer. , 2016, Cancer research.

[37]  J. Trachtenberg,et al.  Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11‐vascular‐targeted photodynamic (VTP) therapy , 2015, BJU international.

[38]  Kevin Burgess,et al.  Fluorescent indicators for intracellular pH. , 2010, Chemical reviews.

[39]  Shannon M. Gallagher-Colombo,et al.  Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms. , 2015, Cancer research.

[40]  M. Baptista,et al.  Enhanced efficiency of cell death by lysosome-specific photodamage , 2017, Scientific Reports.

[41]  N. Mizushima,et al.  How to Interpret LC3 Immunoblotting , 2007, Autophagy.

[42]  M. Baptista,et al.  Photodynamic Efficiency: From Molecular Photochemistry to Cell Death , 2015, International journal of molecular sciences.

[43]  Tayyaba Hasan,et al.  Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates , 2014, Proceedings of the National Academy of Sciences.

[44]  G. Barritt,et al.  Mitochondrial uncoupler FCCP activates proton conductance but does not block store-operated Ca(2+) current in liver cells. , 2010, Archives of biochemistry and biophysics.

[45]  Liyang Cui,et al.  Targeting‐Triggered Porphysome Nanostructure Disruption for Activatable Photodynamic Therapy , 2014, Advanced healthcare materials.

[46]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[47]  G. E. Atilla‐Gokcumen,et al.  Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes , 2017, Molecular Cancer Therapeutics.

[48]  Jianjun Du,et al.  Fluorescent Probes for Sensing and Imaging within Specific Cellular Organelles. , 2016, Accounts of chemical research.

[49]  Tayyaba Hasan,et al.  Size‐dependent Tumor Response to Photodynamic Therapy and Irinotecan Monotherapies Revealed by Longitudinal Ultrasound Monitoring in an Orthotopic Pancreatic Cancer Model , 2018, Photochemistry and photobiology.

[50]  Maurício S. Baptista,et al.  Parallel damage in mitochondrial and lysosomal compartments promotes efficient cell death with autophagy: The case of the pentacyclic triterpenoids , 2015, Scientific Reports.

[51]  Chulhong Kim,et al.  Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. , 2011, Nature materials.

[52]  T. Torres,et al.  Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management. , 2018, Chemical Society reviews.

[53]  Mark D. Savellano,et al.  Targeting Cells That Overexpress the Epidermal Growth Factor Receptor with Polyethylene Glycolated BPD Verteporfin Photosensitizer Immunoconjugates¶ , 2003, Photochemistry and photobiology.

[54]  Michael R Hamblin,et al.  Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. , 2001, Cancer research.

[55]  T. Hasan,et al.  Nanolipid Formulations of Benzoporphyrin Derivative: Exploring the Dependence of Nanoconstruct Photophysics and Photochemistry on Their Therapeutic Index in Ovarian Cancer Cells , 2018, Photochemistry and photobiology.

[56]  Paul M. Ripley,et al.  Photodynamic therapy for cancer of the pancreas , 2002, Gut.